EUVIMEDEUVIMED entdecken
Crossref

Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral Cancer Cells by Inhibiting the PI3K/AKT Pathway

Ching-Huey Yang, Yun-Ching Chang, Chung-Chi Hsu, Cheng-Han Lin, I-Ju Chen, Yen-Ting Wu, Yu-Yan Lan

Anticancer Research · 2023-09 · 43 (9) · 4015-4022

DOI: 10.21873/anticanres.16589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 30.08.2023. Verfasst von Ching-Huey Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Pingtung Veterans General Hospital, Pingtung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Cisplatin, Mouth Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Cisplatin is a drug for treating oral cancer. However, several previous studies indicate that oral cancer cells can develop resistance to cisplatin, which may result in a poor prognosis for patients with oral cancer. Fucoidan, a natural health product extracted from brown seaweed, has anticancer abilities against various types of cancer cell. This study evaluated whether fucoidan can enhance the sensitivity of oral cancer cells to cisplatin and explored the underlying mechanism. MATERIALS AND METHODS: SCC-25 cells were used in the present study and treated with 0.3125 mg/ml fucoidan, 12.5 μg/ml cisplatin, or 0.3125 mg/ml fucoidan plus 12.5 μg/ml cisplatin for 48 h, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, enzyme-linked immunosorbent, and immunoblotting assays were performed to evaluate cell survival, cytokeratin-18 fragment release, and expression of markers of apoptosis and autophagy, respectively. RESULTS: Cotreatment with fucoidan enhanced cisplatin-induced reduction of SCC-25 cell survival compared to cisplatin alone. In addition, cotreatment also increased the expression of apoptosis markers, including activated caspase-8, activated caspase-9, activated caspase-3, and cleaved poly(ADP-ribose) polymerase (PARP), but did not increase the expression of the two autophagy markers studied, beclin and autophagy-related 12-autophagy-related 5 conjugate. Fucoidan significantly inhibited cisplatin-induced AKT serine/threonine kinase 1 activation, which promoted PARP cleavage, caspase-3 activation, and cytokeratin-18 fragment expression in SCC-25 cells. CONCLUSION: Fucoidan promoted cisplatin-induced effects by inhibiting phosphatidylinositol 4,5 bisphosphate 3 kinase/AKT serine/threonine kinase 1 activation induced by cisplatin. The results of this study may provide a basis for the possible application of the combination of fucoidan and cisplatin in the clinical treatment of oral cancer in the future to improve the prognosis of patients with oral cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinMouth NeoplasmsHumansCaspase 3Keratin-18Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPoly(ADP-ribose) Polymerase InhibitorsSerinePolysaccharides

Stichwörter der Autor:innen

Fucoidanapoptosiscisplatinoral cancer

Substanzen

Caspase 3CisplatinKeratin-18Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPoly(ADP-ribose) Polymerase InhibitorsSerinefucoidanPolysaccharides

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Pingtung Veterans General Hospital, Pingtung, Taiwan, R.O.C.
  • Department of Traditional Chinese Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.
  • Department of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan, R.O.C.
  • School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.
  • Department of Pathology, Golden Hospital, Pingtung, Taiwan, R.O.C. wuyengting@hotmail.com.
  • School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.; yyinmed@isu.edu.tw.

Zitieren

APA

Yang, C. H., Chang, Y. C., Hsu, C. C., Lin, C. H., Chen, I. J., Wu, Y. T., & Lan, Y. Y. (2023). Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral Cancer Cells by Inhibiting the PI3K/AKT Pathway. Anticancer Research, 43(9), 4015-4022. https://doi.org/10.21873/anticanres.16589

Vancouver

Yang CH, Chang YC, Hsu CC, Lin CH, Chen IJ, Wu YT, et al. Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral Cancer Cells by Inhibiting the PI3K/AKT Pathway. Anticancer Research. 2023;43(9):4015-4022. doi:10.21873/anticanres.16589

BibTeX
@article{Yang2023,
  author = {Yang, Ching-Huey and Chang, Yun-Ching and Hsu, Chung-Chi and Lin, Cheng-Han and Chen, I-Ju and Wu, Yen-Ting and Lan, Yu-Yan},
  title = {Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral Cancer Cells by Inhibiting the PI3K/AKT Pathway},
  journal = {Anticancer Research},
  year = {2023},
  volume = {43},
  number = {9},
  pages = {4015--4022},
  doi = {10.21873/anticanres.16589}
}
Kostenlos starten →